Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision Home OCT

Description

Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision Home OCT The purpose of this study is to collect data on the NVHO device at up to three sites.

Conditions

Diabetic Macular Edema

Talk to us

Study Overview

On this page

Study Details

Study overview

Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision Home OCT The purpose of this study is to collect data on the NVHO device at up to three sites.

Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision

Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision Home OCT

Condition
Diabetic Macular Edema
Intervention / Treatment

-

Contacts and Locations

Baltimore

Elman Retina Group, PA, Baltimore, Maryland, United States, 21237

Fairfax

The Retina Group of Washington, Fairfax, Virginia, United States, 22031

Norfolk

Wagner Kapoor Research Institute, Norfolk, Virginia, United States, 23502

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Ability to speak, read and understand English.
  • * Ability to agree, understand and sign the informed consent form.
  • * Eighteen (18) years of age or older at the time of Informed Consent.
  • * Subjects diagnosed with DR (Diabetic Retinopathy) in at least one eye, with or without DME
  • * Best corrected Visual Acuity of 20/320 (6/96) or better in eyes participating at the study.
  • * Subjects with dilated pupils.
  • * Subjects with other retinal disease requiring steroidal or anti-VEGF injections

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Notal Vision Inc.,

Study Record Dates

2023-07-31